Searched for
STENT MAKERS
Govt mulls over new category for advanced coronary stents, price ceiling increase to attract manufacturersThe government is considering creating a separate category for advanced coronary stents and raising the price ceiling to attract stent make...- Operation buyout: KKR, TPG, and other PE firms eye purchase of India's largest cardiac stent maker SMTMorgan Stanley PE Asia and Samara Capital collectively own 49% of the company while Kotak Pre IPO Opportunities Fund holds 6%. The Kotadias...
- Companies seek higher ceiling prices for advanced coronary stentsThe Standing National Committee on Medicines (SNCM), in its recommendation, included coronary stents in the NLEM, 2022 in two categories --...
- Stents price capping has improved its accessibility: Drug pricing regulator NPPAAccording to the National Pharmaceutical Pricing Authority (NPPA) both stent manufactured and imported went up from 9.36 lakh in 2016 to 13...
- Panel likely to study stent companies' demand on price capWith the committee not finding any “therapeutic advantage” in these stents that favours price exemption, the issue is likely to be sent to ...
- How reduction in stent prices has made domestic players competitiveThe reduction in stent prices enthused Indian manufacturers, which had been on the fringes of the business and had been desperately trying ...
- Stent prices under the cosh again, but who will bell the real cat?The decision is a blow for stent makers, who have been clamouring for higher prices and a system to rationalise margins instead of blanket ...
- Domestic stent makers gain on the back of price capsThis year, domestic stent firms are aiming for 60 per cent of the market estimated to be Rs 1,200 crore now due to a drop in the average pr...
- Stent makers want government to apply differential pricing for Drug-eluting stentsDrug-eluting stents (DES) have a polymer coating over mesh that emits a drug over time that prevent blockage of arteries from recurring.
- Centre cracks whip, no stent can be withdrawn, for nowThe department of pharmaceuticals (DoP) said it had come across reports regarding shortage of coronary stents in the market and in hospital...
- Three MNC pharma companies want to recall its new generation stents from IndiaIt's not clear if firms can withdraw their products as the Department of Pharmaceuticals had recently prevented stent makers from taking th...
- No shortage of stents in the country: NPPAThe National Pharmaceutical Pricing Authority (NPPA) met stent makers and importers today to discuss issues like pricing and availability o...
- NPPA asks hospitals, stent makers to list prices on websitesThe instructions are being issued in public interest for compliance of ceiling prices by stent makers, distributors and hospitals, the NPPA...
- NPPA slashes margins on stents for hospitals, distributorsNow, patients purchasing stents at their maximum price won’t pay hospitals margins of more than Rs 2,400 on DES and BVS and about Rs 581 on...
- Stent companies fight to stay afloat, but patients wary after capFollowing the NPPA decision, some companies have reportedly withdrawn high-priced stents, leading to an artificial shortage of the product.
- Price cap on stents opens the floodgates for new realitiesA cardiologist who spoke to ET on condition of anonymity said some companies, especially importers, have asked hospitals not to use stents ...
- Price caps will save patients nearly Rs1 lakh on cardiac stents: Ananth KumarThe move, which has upset domestic and multinational stent makers alike, would encourage companies to make in India to cut costs, the minis...
- NPPA seeks info about pricing, products from stent makersThe National Pharmaceutical Pricing Authority (NPPA) has also called for a meeting with the stakeholders to discuss the issue on January 24.
- NPPA proposes to slash cardiac stent prices by 50%The body has proposed that ceiling prices of drug-eluting stents (DES) be fixed at rates ranging between Rs21,881 to Rs67,272—less than 50%...
- NPPA asks stent makers to furnish pricing data within a weekThe drug pricing watchdog stated that few companies still have not submitted the information and that some of them have not submitted the d...
Load More
